Announcements Trials
Browse Landscape

Phase

Phase 2 25Phase 3 6Phase NA 4Phase 1 4Phase 1/2 2Phase 4 1Phase 2/3 1

Status

Completed 37Recruiting 35Unknown 33Not yet recruiting 12Active not recruiting 7Withdrawn 4Terminated 4Enrolling by invitation 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Genitourinary 1

Conditions

Prostatic Neoplasms 1Pancreatic Neoplasms 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Radiosurgery 20Magnetic Resonance Spectroscopy 20Exercise 15Biopsy 11Surveys and Questionnaires 9Standard of Care 9Cyclophosphamide 9Educational Status 8Practice Guidelines as Topic 7Doxorubicin 7Cisplatin 7Therapeutics 6Radiotherapy 6Methods 6Fluorodeoxyglucose F18 6Early Intervention, Educational 6Blood Specimen Collection 6Radiotherapy, Intensity-Modulated 5Electroporation 5Cryosurgery 5Colonoscopy 5X-Rays 4Water 4Vincristine 4Polymerase Chain Reaction 4Palliative Care 4Irinotecan 4Drug Therapy 4Diet Therapy 4Cryotherapy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase NA × Withdrawn × Drug Therapy × Clear all
NCT05488626 2026-02-05

ARTIA-Lung

Varian, a Siemens Healthineers Company

Phase NA Withdrawn
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04420130 2022-10-04

A Trial of Camrelizumab Combined With Ablation and Chemotherapy in Patients With Pancreatic Cancer Liver Metastasis(SHR-1210-HLJ-009)

Harbin Medical University

Phase NA Withdrawn
Gastrointestinal

Pancreatic Neoplasms

NCT03532204 2019-05-22

OLIVER

UNICANCER

Phase NA Withdrawn
Gastrointestinal

Colorectal Neoplasms

NCT01811810 2019-04-23

Proton Therapy for High Risk Prostate Cancer

Abramson Cancer Center at Penn Medicine

Phase NA Withdrawn
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡